Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.808 USD | +1.75% | +1.75% | -2.83% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
Business Summary
Number of employees: 32
Managers
Managers | Title | Age | Since |
---|---|---|---|
Prashant Kohli
CEO | Chief Executive Officer | 52 | 21-07-31 |
Director of Finance/CFO | 52 | Jan. 04 | |
Carrie D'Andrea
CTO | Chief Tech/Sci/R&D Officer | 52 | 23-05-07 |
Robert Macdonald
CTO | Chief Tech/Sci/R&D Officer | 62 | 23-05-07 |
Amresh Kumar
PRN | Corporate Officer/Principal | 44 | 23-05-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
A. Davis
BRD | Director/Board Member | 57 | 23-10-09 |
Director/Board Member | - | 23-10-09 | |
Santosh Kottayil
BRD | Director/Board Member | - | 23-10-09 |
Chairman | 55 | 21-08-26 | |
Prashant Kohli
CEO | Chief Executive Officer | 52 | 21-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,399,404 | 7,893,546 ( 83.98 %) | 0 | 83.98 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.83% | 25.94M | |
+32.06% | 694B | |
+29.39% | 593B | |
-1.58% | 371B | |
+19.84% | 331B | |
+6.90% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.11% | 169B |
- Stock Market
- Equities
- ACST Stock
- Company Acasti Pharma Inc.